Table 5 Participant characteristics of questionnaire survey by persona

Age, years: Mean ± SD

55.20 ± 12.10

53.82 ± 13.56

59.16 ± 11.07

50.42 ± 13.92

60.1 ± 9.42

56.05 ± 9.10

Time of diagnosis, years: Mean ± SD

5.62 ± 12.07

3.21 ± 2.02

3.64 ± 2.72

7.41 ± 21.22

8.62 ± 19.42

7.03 ± 9.76

BMI, kg/m²: Mean ± SD

22.98 ± 2.31

22.83 ± 2.39

23.26 ± 2.44

22.89 ± 2.27

23.37 ± 1.96

22.92 ± 2.72

Chemotherapy cycle: Mean ± SD

4.00 ± 2.24

3.20 ± 1.50

4.03 ± 2.47

3.70 ± 1.38

4.39 ± 3.03

4.09 ± 2.63

Ethnicity

Han

94 (98.95%)

26 (96.30%)

36 (100%)

25 (100%)

35 (100%)

18 (100%)

Others

1 (1.05%)

1 (3.70%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Educational level

Primary school or below

9 (9.47%)

2 (7.41%)

6 (16.67%)

3 (12.00%)

3 (8.57%)

1 (5.56%)

Middle school

15 (15.79%)

3 (11.11%)

4 (11.11%)

4 (16.00%)

10 (28.57%)

2 (11.11%)

High school

34 (35.79%)

8 (29.63%)

16 (44.44%)

7 (28.00%)

11 (31.43%)

7 (38.89%)

College or above

37 (38.95%)

14 (51.85%)

10 (27.78%)

11 (44.00%)

11 (31.43%)

8 (44.44%)

Marital Status

Married/ In a relationship

88 (92.63%)

25 (92.59%)

34 (94.44%)

22 (88.00%)

35 (100%)

17 (94.44%)

Single / Divorced / Widowed

7 (7.37%)

2 (7.41%)

2 (5.56%)

3 (12.00%)

0 (0%)

1 (5.56%)

Residence area

City

82 (86.32%)

20 (74.07%)

33 (91.67%)

22 (88.00%)

32 (91.43%)

17 (94.44%)

Town

9 (9.47%)

6 (22.22%)

2 (5.56%)

1 (4.00%)

1 (2.86%)

1 (5.56%)

Village

4 (4.21%)

1 (3.71%)

1 (2.77%)

2 (8.00%)

2 (5.71%)

0 (0%)

Employment status

Employed

21 (22.11%)

7 (25.93%)

5 (13.89%)

12 (48.00%)

7 (20.00%)

5 (27.78%)

Sick leave/ Unemployed

23 (24.21%)

8 (29.63%)

8 (22.22%)

7 (28.00%)

8 (22.86%)

4 (22.22%)

Retired

51 (53.68%)

12 (44.44%)

23 (63.89%)

6 (24.00%)

20 (57.14%)

9 (50.00%)

Family income (RMB)

< 3000

3 (3.16%)

0 (0%)

3 (8.33%)

2 (8.00%)

1 (2.86%)

0 (0%)

3000–5000

35 (36.84%)

8 (29.63%)

15 (41.67%)

7 (28.00%)

14 (40.00%)

5 (27.78%)

5000–10,000

45 (47.37%)

13 (48.15%)

16 (44.44%)

13 (52.00%)

18 (51.43%)

10 (55.56%)

>10,000

12 (12.63%)

6 (22.22%)

2 (5.56%)

3 (12.00%)

2 (5.71%)

3 (16.66%)

Health insurance

Without health insurance

4 (4.21%)

0 (0%)

3 (8.330%)

0 (0%)

7 (20.00%)

0 (0%)

Rural program

1 (1.05%)

0 (0%)

0 (0%)

0 (0%)

1 (2.86%)

0 (0%)

Citizen program

62 (65.27%)

16 (59.26%)

27 (75.00%)

4 (16.00%)

26 (74.28%)

11 (61.11%)

Employee health insurance

27 (28.42%)

11 (40.74%)

6 (16.67%)

21 (84.00%)

1 (2.86%)

6 (33.33%)

Others

1 (1.05%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

1 (5.56%)

Granulocyte colony-stimulating factors (G-CSFs) used

No

79 (83.16%)

25 (92.59%)

31 (86.11%)

21 (84.00%)

25 (71.43%)

13 (72.22%)

Yes

16 (16.84%)

2 (7.41%)

5 (13.89%)

4 (16.00%)

10 (28.57%)

5 (27.78%)

Chemotherapy type

Neoadjuvant chemotherapy

30 (31.58%)

9 (33.33%)

12 (33.33%)

9 (36.00%)

5 (31.43%)

5 (27.78%)

Postoperative chemotherapy

65 (68.42%)

18 (66.67%)

24 (66.67%)

16 (64.00%)

24 (68.57%)

13 (72.22%)

Daily average screen time

<4 h

9 (9.48%)

15 (55.56%)

4 (11.12%)

3 (12.00%)

4 (11.43%)

0 (0%)

4–6 h

33 (34.74%)

10 (37.04%)

16 (44.44%)

7 (28.00%)

17 (48.57%)

3 (16.67%)

>6 h

53 (55.78%)

2 (7.740%)

16 (44.44%)

15 (60.00%)

14 (40.00%)

15 (83.33%)